Description
The Comprehensive Digestive Stool Analysis (CDSA)™ is Genova’s historic stool profile providing an informative and flexible screening of gastrointestinal function.
This stool analysis evaluates:
-
- Digestion/Absorption:
- Chymotrypsin
- Putrefactive Short–Chain Fatty Acids
- Meat and Vegetable Fibers
- Fecal Fats
- Digestion/Absorption:
-
- Gut Metabolic Markers
- Beneficial Short–Chain Fatty Acids (SCFA) with n–Butyrate
- n–Butyrate
- Beta-Glucuronidase
- pH
- SCFA distribution
- Fecal Lactoferrin
- Macroscopic (color, mucus)
- Occult Blood
- Gut Metabolic Markers
-
- Gut Microbiology Markers
- Beneficial Bacteria
- Additional Bacteria
- Mycology
- Parasitology Microscopic
- Parasitology EIA
- Cryptosporidium
- Giardia lamblia
- Entamoeba histolytica
- Gut Microbiology Markers
When should the CDSA/P be considered?
CDSA/P can reveal important clinical information about many common symptoms such as gas, bloating, abdominal pain, diarrhea, and constipation. Fecal Lactoferrin and Occult Blood provide insight into potential gut inflammation. In addition, patients with risk factors for parasite acquisition can be evaluated with the CDSA/P.
What advantage does CDSA/P offer compared to other diagnostics?
Traditional GI testing has required advanced imaging and inconvenient testing procedures that can be costly. The CDSA/P stool analysis offers a user-friendly way to provide clinicians with valuable insight into GI imbalances.
What can clinicians and patients expect from the CDSA/P offer compared to other diagnostics?
Evidence suggests that both local and systemic health issues may begin as imbalances in Gastrointestinal function. The CDSA/P stool test provides immediate, actionable clinical information for patients presenting with GI complaints. It aids clinicians in the identification of root cause(s) of digestive discomfort and supports identification of targeted treatments.